Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications response cost meningococcal disease outbreaks university campus settings case study
… - UK MSc, Health Economics and Decision Modelling University of Sheffield, Sheffield, United Kingdom BSc, … Related Research. His dissertation focused on developing cost-effectiveness and budget-impact models for Alzheimer’s disease. During his time at RTI-HS, Mr. Brockbank has …
… North Carolina, USA PhD, Epidemiology MSPH, Epidemiology University of North Carolina at Chapel Hill, Chapel Hill, NC … in the field of pharmacoepidemiology. His experience and publications span a wide range of substantive areas, … focusing in pharmacoepidemiology with an emphasis in renal disease. Prior to joining RTI-HS, he was a member of the …
… considered, perspectives used, discounting rates used for cost and outcomes, and willingness-to-pay thresholds. …
… Meeting in May 2022. Ashley presented research on the cost-effectiveness of every two month versus daily …
… William L Herring Health Economics Infectious Disease Hematology Vaccines Respiratory Ophthalmology … Applied (Operations Research) MSc, Mathematics, Applied University of Maryland at College Park, College Park, MD BSc, … with RTI-HS, Dr. Herring has developed an expertise in cost-effectiveness and value-based pricing modeling, and his …
… Coursework Towards Master of Arts, Education New York University, New York, NY Culinary Management Program …
… average) on every aspect except for the treatment under study. Thus, any observed differences in outcomes can be … courses of action, the framework eases discussions on the study design among stakeholders. Additionally, it helps avert …
… Studies Lyon, France PhD, Genetics MD, Biology/Genetics University of Vienna, Vienna, Austria PD, Sales and Marketing Business University of Vienna, Vienna, Austria Dr. Sluga-O’Callaghan … women’s health, oncology, urology, neurology, respiratory disease, and psychiatry. …
… Strategy Telecommuter - USA MBA, Business Administration University of Michigan, Ann Arbor, MI PhD, Computational … Institute, Troy, NY BS, Biotechnology Montana State University, Bozeman, MT Patrick Buck has more than 10 years …
… companies responding on several levels. Portfolio-Level Response Because small molecules or multiple-indication … include more large-molecule drugs or biologicals instead. Disease-Level Response Companies might be thinking of … Clinical Assessments: Racing to the Finish Line at What Cost? Advancements in EU Health Technology Regulation and …